OTCMKTS:MSSTF Mindset Pharma (MSSTF) Stock Price, News & Analysis → Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars (From GoldenCrest Metals) (Ad) Free MSSTF Stock Alerts $0.54 0.00 (-0.37%) (As of 10/24/2023) Add Compare Share Share Today's Range$0.54▼$0.5450-Day Range$0.54▼$0.5452-Week Range$0.16▼$0.56Volume900 shsAverage Volume33,313 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Mindset Pharma alerts: Email Address Ad GoldenCrest MetalsExposed: How Big Banks Plan to Chain Your Wealth with Digital DollarsBig Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver.Learn More Now About Mindset Pharma Stock (OTCMKTS:MSSTF)Mindset Pharma Inc. develops and sells psychedelic medicines to treat neurological and psychiatric disorders in Canada. It focuses on developing MSP-1014, a psychedelic drug candidate. The company is based in Toronto, Canada.Read More MSSTF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MSSTF Stock News HeadlinesApril 22, 2024 | seekingalpha.comNvidia: Significant Downside Risks As Its Customers Develop AI ChipsApril 10, 2024 | msn.comMorocco's investments in Africa, an asset for the continentApril 24, 2024 | GoldenCrest Metals (Ad)Exposed: How Big Banks Plan to Chain Your Wealth with Digital DollarsBig Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver.April 4, 2024 | msn.comThe evolving field of software product management, how can working professionals react to it?March 29, 2024 | msn.com‘AI and aai sound similar’, PM Modi tells Bill GatesMarch 18, 2024 | forbes.comSlow The Flow: 3 Ways Smart Leaders Decide In A Noisy WorldMarch 15, 2024 | msn.comRonnie O'Sullivan leaves snooker legend in a quandary as Rocket aims to make more historyMarch 12, 2024 | tmcnet.comAION Labs Launches CombinAble.AI to Reduce Time and Cost of Targeted Antibody Design, Advancing Optimization of Drug DevelopmentApril 24, 2024 | GoldenCrest Metals (Ad)Exposed: How Big Banks Plan to Chain Your Wealth with Digital DollarsBig Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver.March 6, 2024 | benzinga.comHow Mindset Builds The Foundation For Personal and Professional Success - A Look Through Shane Quigley's LensFebruary 28, 2024 | forbes.comSaving Telco From Itself: Overcoming The Top 5 Challenges In 2024February 8, 2024 | msn.comQuite bullish and overweight on pharma stocks: Vikas KhemaniFebruary 2, 2024 | uk.finance.yahoo.comQ1 2024 Becton Dickinson and Co Earnings CallFebruary 1, 2024 | finance.yahoo.comAlginates & Derivatives Market worth $651 million by 2028 - Exclusive Report by MarketsandMarkets™October 25, 2023 | finanznachrichten.deMindset Pharma Inc.: Mindset Pharma Announces Receipt of Final OrderOctober 25, 2023 | finance.yahoo.comMindset Pharma Announces Receipt of Final OrderOctober 5, 2023 | finanznachrichten.deMindset Pharma Inc.: Mindset Pharma Provides Clarifying Disclosure in Connection with Proposed Plan of ArrangementSeptember 25, 2023 | proactiveinvestors.comMindset Pharma updates investors on Otsuka Pharmaceutical transactionSeptember 22, 2023 | finance.yahoo.comMindset Pharma Announces Mailing of Circular and Receipt of Interim OrderAugust 31, 2023 | proactiveinvestors.comMindset Pharma to be acquired by Otsuka Pharmaceutical in all-cash...August 31, 2023 | benzinga.comMindset Pharma's $60M Acquisition, Otsuka's Leap Into Next-Gen Psychiatry SolutionsAugust 3, 2023 | investing.comMindset Pharma Inc (MSET)July 18, 2023 | benzinga.comTerran Biosciences Steps Into 4-OH-DiPT Prodrug Arena With New Patent ApplicationJuly 4, 2023 | msn.comPsyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & MoreJune 27, 2023 | msn.comUK Greenlights Phase 2 Clinical Trial On Mindset Pharma's Psilocin Drug For Major DepressionJune 24, 2023 | proactiveinvestors.comMindset Pharma's Phase 2 psilocin prodrug study gets green light from UK regulatorsJune 22, 2023 | finanznachrichten.deMindset Pharma Inc.: Mindset Pharma Receives Approval for Phase II Clinical Trial Evaluating MSP-1014 for the Treatment of Major Depressive DisorderSee More Headlines Receive MSSTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mindset Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:MSSTF CUSIPN/A CIKN/A Webwww.mindsetpharma.com PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. James Andre-Charles Lanthier (Age 48)Chief Executive Officer Comp: $567.24kMr. Arvin Ramos CPA (Age 45)Chief Financial Officer Comp: $116.43kMr. Joseph Araujo (Age 47)Chief Scientific Officer, Member of Scientific Advisory Board & Director Comp: $603.43kDr. Abdelmalik Slassi Ph.D.Senior VP of Innovation & Member of Scientific Advisory BoardMr. Jason Atkinson (Age 35)Head of Corporate Development Comp: $108.56kMr. Christopher E.O. Irwin B.A. (Age 49)L.L.B., L.L.M., Q.C., Corporate Secretary More ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors MSSTF Stock Analysis - Frequently Asked Questions How have MSSTF shares performed in 2024? Mindset Pharma's stock was trading at $0.5381 at the start of the year. Since then, MSSTF shares have increased by 0.0% and is now trading at $0.5381. View the best growth stocks for 2024 here. How do I buy shares of Mindset Pharma? Shares of MSSTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MSSTF) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mindset Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
